IGC Pharma, Inc. — Director's Dealing 2017

Dec 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: India Globalization Capital, Inc. (IGC)
CIK: 0001326205
Period of Report: 2017-12-04

Reporting Person: PRINS RICHARD K (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-12	Common Stock	G	2000	—	Disposed	497000	Direct
2017-05-19	Common Stock	G	2000	—	Disposed	495000	Direct
2017-05-26	Common Stock	G	2000	—	Disposed	493000	Direct
2017-06-02	Common Stock	G	2000	—	Disposed	491000	Direct
2017-06-09	Common Stock	G	2000	—	Disposed	489000	Direct
2017-06-16	Common Stock	G	2000	—	Disposed	487000	Direct
2017-06-23	Common Stock	G	2000	—	Disposed	485000	Direct
2017-06-30	Common Stock	G	2000	—	Disposed	483000	Direct
2017-07-07	Common Stock	G	2000	—	Disposed	481000	Direct
2017-07-14	Common Stock	G	2000	—	Disposed	479000	Direct
2017-07-21	Common Stock	G	2000	—	Disposed	477000	Direct
2017-07-28	Common Stock	G	2000	—	Disposed	475000	Direct
2017-08-04	Common Stock	G	2000	—	Disposed	473000	Direct
2017-08-11	Common Stock	G	2000	—	Disposed	471000	Direct
2017-08-18	Common Stock	G	2000	—	Disposed	469000	Direct
2017-08-25	Common Stock	G	2000	—	Disposed	467000	Direct
2017-09-01	Common Stock	G	2000	—	Disposed	465000	Direct
2017-09-08	Common Stock	G	2000	—	Disposed	463000	Direct
2017-09-15	Common Stock	G	2000	—	Disposed	461000	Direct
2017-09-22	Common Stock	G	2000	—	Disposed	459000	Direct
2017-09-29	Common Stock	G	2000	—	Disposed	457000	Direct
2017-10-06	Common Stock	G	2000	—	Disposed	455000	Direct
2017-10-13	Common Stock	G	2000	—	Disposed	453000	Direct
2017-10-20	Common Stock	G	2000	—	Disposed	451000	Direct
2017-10-27	Common Stock	G	2000	—	Disposed	449000	Direct
2017-11-03	Common Stock	G	2000	—	Disposed	447000	Direct
2017-11-10	Common Stock	G	2000	—	Disposed	445000	Direct
2017-11-17	Common Stock	G	2000	—	Disposed	443000	Direct
2017-11-24	Common Stock	G	2000	—	Disposed	441000	Direct
2017-12-01	Common Stock	G	2000	—	Disposed	439000	Direct